Can this result diagnose a condition on its own?

No. The result should be interpreted with symptoms, medical history, assay method and related tests.

Which reference range should I use?

Use the performing laboratory's own reference or decision range and reporting method first.

When should I discuss the result with a healthcare professional?

Reactive/positive, clearly abnormal, persistent or symptom-associated results should be reviewed by a healthcare professional.

Information about a laboratory test

CA 19-9 High Result: What Does It Mean?

A high tumor marker does not diagnose cancer on its own; benign conditions and other causes can also raise the level.

Test summary

Test name: CA 19-9
Abbreviations: CA 19-9, CA19-9
Category: Tumor Markers / Gastroenterology
Panel: Tumor Marker Monitoring
Specimen: Serum / plasma
Common units: U/mL

What does the test measure?

CA 19-9 measures the relevant tumor marker in blood.

Why is the test ordered?

CA 19-9 may be used with other clinical information for especially monitoring treatment response and disease course in pancreatic and biliary cancers.

Information about a low result

A low/normal tumor marker does not rule out cancer by itself.

Information about a high result

A high tumor marker does not diagnose cancer on its own; benign conditions and other causes can also raise the level.

Reference and clinical context

Start with the performing laboratory's reference or decision range, assay method, specimen and reporting unit. A single result usually does not establish a diagnosis on its own.

Reference ranges may vary by laboratory, method used, age, sex, pregnancy status, and clinical context. The reference range on your own laboratory report takes precedence.

Interpretation notes

Tumor markers are often more useful for monitoring known disease and selected clinical evaluations than as stand-alone diagnostic tests.

Related specialties

Oncology
Internal Medicine

Frequently asked questions

Sources

Tumor Marker Tests in Common Use — National Cancer Institute
U.S. government cancer reference · 2023 · Common tumor markers and typical monitoring uses · Verified: Aug 12, 2026
CA 19-9 Blood Test (Pancreatic Cancer) — U.S. National Library of Medicine (MedlinePlus)
Government medical reference · 2026 · CA 19-9 use, assay dependence and monitoring context · Verified: Aug 12, 2026